Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-19

Clinical Trial Update: Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors [EARLY_Phase 1]

View source ↗

Summary

This document reports an early-phase 1 clinical study of GT201 for advanced gynecologic tumors, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GT201

Snippet

Sponsor: Grit Biotechnology | Conditions: Adult Gynecological Tumors | EARLY_Phase 1 | Status: RECRUITING